The sounds of silence have forever been broken as genetics and genomics approaches in human and model organisms have provided a powerful and rapid entry into gene discovery in the auditory system. An understanding of the complexities and beauty of the biological process of hearing itself is unfolding as genes underlying hereditary hearing impairment are identified. Genes involved in modifying hearing are also being found, and will be critical to a full comprehension of genotype-phenotype relationships. Investigations in the auditory system will provide important insight into how the nervous system decodes molecular information. Deafness represents a common sensory disorder that can interfere dramatically in the acquisition of speech and language in children, and in the quality of life for a growing aged population. As newborn screening for hearing impairment is being implemented in many birth hospitals, the prospects for precise clinical diagnosis, appropriate genetic counseling and proper medical management for auditory disorders has never been at a more exciting crossroad.
INTRODUCTION
It has long been recognized that heredity plays a major role in hearing impairment. Despite the fact that understanding the genetic basis of hearing loss has fascinated human and medical geneticists for decades, only within the past few years have the genes and molecular mechanisms underlying deafness begun to be discovered. In part, this results from various obstacles to investigation of the auditory system including: inaccessibility of the sensory end organ for hearing, the cochlea, within the dense temporal bone; length of time to direct pathologic observation of the deaf ear due to an otherwise normal lifespan of individuals with hearing loss; unparalleled genetic heterogeneity; and assortative mating. The history of the genetics of deafness has had a sordid past of blatant discrimination of the deaf (1), and there is mistrust about genetics among some members of the deaf population. Nevertheless, the past few years have witnessed an explosion of discoveries that are providing fundamental insight into the biology of hearing.
The frequency of hearing loss is estimated at one per thousand newborns and half of all cases are attributed to genetic causes. In addition to being a common etiology of congenital deafness, mutations in genes are responsible for progressive hearing loss, and no doubt will be found to play an important role in progressive hearing loss with ageing (presbycusis). Environmental etiologies of hearing loss are likely to represent a declining proportion of cases as better therapies for bacterial and viral infections (e.g. vaccines) are implemented, acoustic trauma in the workplace is recognized and prevented, and ototoxic drugs (e.g. aminoglycosides) are avoided in genetically susceptible individuals.
GENETICS OF DEAFNESS
The study of the genetics of deafness is unique among inherited disorders for several reasons and illustrates well various concepts in human genetics. Notably, there is incomparable genetic heterogeneity with over 90% of matings among the deaf resulting in all hearing offspring. This reflects matings among the deaf with mutations in different genes as well as matings of couples in which one individual is deaf due to a genetic mechanism and the other due to an environmental etiology. Matings among the deaf are well recognized and, with the exception of assortative mating for stature, may represent one of the most common genetic traits on which an altered mating structure occurs in human populations. Furthermore, the hearing offspring of deaf couples who themselves can be native signers are more likely than random members of the population to have a partner who is deaf due to a shared language and culture. Both genetic heterogeneity and assortative mating confound gene discovery using traditional methods of genetic linkage analysis. Hundreds of syndromic forms of deafness have been described (2) (3) (4) and the underlying genetic mutation identified for many of the more common forms, but only 30% of genetic cases are estimated to be part of a heritable syndrome. Thus, the vast majority of genetic deafness is designated as nonsyndromic and to date over 65 loci have been mapped. Nonsyndromic hearing impairment is categorized further by mode of inheritance: approximately 77% of cases are autosomal recessive; 22% autosomal dominant; 1% X-linked; and < 1% due to mitochondrial inheritance (5) . Dominant loci are designated with the prefix 'DFNA', recessive loci 'DFNB', X-linked loci 'DFN' and modifying loci with 'DFNM'. Generally, patients with autosomal recessive hearing impairment have prelingual and congenital deafness and patients with autosomal dominant hearing impairment have postlingual and progressive hearing impairment. This observation may be explained by the complete absence of functional protein in recessive disorders, while in autosomal dominant disorders, dominant mutations may be consistent with initial function and subsequent hearing impairment due to a cumulative, degenerative process. A recent tally of nonsyndromic hearing loss disorders reveals 32 autosomal dominant, 27 autosomal recessive, and 4 X-linked forms (4) . It remains to be shown whether each of these loci will correspond to a unique gene. In fact, various deafness disorders have been found already to be the result of the same genetic etiology (e.g. DFNA8 and A12; DFNA6, A14 and A38). In addition, at least 58 auditory genes have been identified: 16 for autosomal dominant and 11 for autosomal recessive loci, and 1 for an X-linked locus; 6 mitochondrial genes and at least 38 genes for syndromic hearing loss have also been discovered (n.b. some genes cause multiple forms of deafness) ( Table 1) . Although this magnitude of progress is remarkable and significant advances have been made, it is clear that many more genes for hearing await detection.
Mutations within the same gene have been found to result in a variety of clinical phenotypes with different modes of inheritance. For example, mutations in MYO7A are pathogenetic in the autosomal recessive deafness and blindness disorder Usher syndrome type 1B (USH1B), and in two nonsyndromic hearing disorders, DFNB2 and DFNA11, displaying autosomal recessive and dominant segregation, respectively. It has been suggested that the mutation in DFNA11, a 9 bp deletion in the coiled-coil domain of MYO7A which is involved in dimerization, could have a dominant negative effect (6) as compared to splicing and missense mutations observed in recessive USH1B and DFNB2 (7) (8) (9) . Another example of phenotypic heterogeneity also involving Usher syndrome is seen in mutations in CDH23 detected in USH1D and DFNB12 (10, 11) . Mutations in PDS cause Pendred syndrome and nonsyndromic autosomal recessive Table 2 . In addition to sequence-based approaches, gene expression chips provide an important means to explore the repertoire of cochlear messages in the normal and diseased state. Data from gene chip assays are available on the web for normal mouse cochlea for ages P2 and P32 (42) . Several preferentially expressed cochlear genes, namely COCH (43) and OTOR (44,45), have been identified from the human fetal cochlear cDNA library; COCH was further shown to be responsible for a sensorineural deafness and vestibular disorder, DFNA9 (22) . Various genes have been identified from a similar approach using mouse inner ear transcripts and include Otog (37), Ocn95 (46), Ush1c (30), Fdp (mouse homolog of OTOR) (47) and Strc (31); the human homolog of Ush1c was found to underlie mutations in USH1C and of Strc to be etiologic in DFNB16.
Mouse models for discovery of hearing genes
Identification of mouse models of specific forms of deafness is of great interest as the mouse is clearly the model organism of choice for the study of hearing loss in humans. The mouse cochlea is highly similar in structure to that of the human. Studies of mouse mutants from fetal to adult ages makes possible investigation into the pathology at developmental time points simply not possible in humans. Of particular relevance to understanding the pathobiology and underlying molecular mechanisms of genetic mutations is the ability to evaluate early developmental stages in mouse mutants because hair cell defects may result from degenerative processes secondary to a primary abnormality in another cell type. Although there has been tremendous progress in identifying genes underlying deafness, there are still relatively few mouse models (Table 3) . In some instances, identification of the mouse mutation has greatly preceded detection of the human disorder (48,49), 
Usher syndrome type 1D (USH1D), DFNB12 (10, 11, 177) whereas in other cases discovery of the genetic basis for deafness has occurred concurrently (12, 50) . Positional cloning of deafness genes in the mouse is facilitated by the ability to breed large numbers of mice with the same mutation to narrow the interval for study. A large screen of inbred mouse strains by ABR threshold analyses at The Jackson Laboratory is currently underway, and likely to identify mutants that will lead to discovery of new genes and modifying genes for deafness (51) . In addition, large numbers of new mouse mutants for investigating mammalian gene function including deafness are being generated rapidly through ENU mutagenesis (52) . This chemical mutagenesis program also makes possible genedriven approaches to mouse mutants and using this approach, two missense and one stop mutation were recently identified in Gjb2, the most common cause of nonsyndromic deafness in the human population (53) . Besides the spontaneous deaf mouse mutants and those generated from mutagenesis programs, a number of gene targeting experiments have been performed following identification of the human gene, and have provided valuable mouse mutants for investigation. As the human and mouse DNA sequencing projects are finished, the mousehuman synteny maps will also become better defined and it will become increasingly easier to locate potential mouse mutants for mapped human deafness disorders.
GENE DISCOVERY IN THE AUDITORY SYSTEM: THE PATH TO IMPROVED DIAGNOSIS AND CLINICAL CARE
Inspection of the genes identified in hearing disorders and those among the gene lists from the EST sequencing projects reveals a great diversity of transcripts, perhaps not surprising due to the large variety of cells and complexity of the inner ear. The finding of a large percentage of cochlear ESTs not identified in any other tissue may indicate the existence of genes that are unique to the cochlea. Certainly, the great degree of genetic heterogeneity reflected in the many different syndromes involving hearing loss and mapped loci is indicative of a large number of genes orchestrating the hearing process. Grouping the genes discovered to be etiologic in deafness disorders into functional categories begins the process of understanding their role in hearing. Knowledge of the pathways in which many of these genes function will be an exciting journey in hearing science; no doubt pathways exist that are not yet imagined. Another important aspect of gene discovery for deafness disorders is that it makes possible the development of diagnostic tests and accurate genetic counseling. Appropriate medical management and therapeutic options may be based on an understanding of the specific disorder.
Gap junction proteins: the connexins
Prominent among the group of genes are those encoding gap junctions. A somewhat surprising finding in the field has been the prevalence of mutations in a single gene encoding the gapjunction protein connexin 26, GJB2, accounting for up to 50% of all cases of autosomal recessive prelingual deafness in tested populations (54) (55) (56) (57) (58) (59) (60) (61) (62) (63) (64) (65) . Connexin 26 gap junctions are believed to play a critical role in the recycling of potassium ions from their entry into hair cells during sensory transduction from the endolymph through to the stria vascularis, where other potassium channels pump potassium back into the endolymph. The gap junction itself, the connexon, is formed from six monomers of connexin and forms a pore between cells by binding with a connexon on an adjacent cell. Several recurrent mutations have been found in GJB2 (e.g. 35delG, 167delT, and 235delC), some with ethnic predilections. In addition to the recurrent mutations, the gene is small (681 bp) making it especially amenable for genetic testing. Screening for mutations in GJB2 has already emerged as the cornerstone of genetic testing for hearing loss and has been incorporated in some centers into the clinical work-up of infants who fail newborn hearing tests. The connexin-deafness homepage provides information on connexin mutations in deafness ( Table 2) . Besides GJB2, genes for other gap junction proteins have been found to be associated with hearing loss including GJB3 (26), GJB6 (66) and GJA1 (67) . A curious finding in genetic testing of the deaf for GJB2 has been the frequent observation of heterozygosity for a mutation. Various explanations have been proposed including the possibility that the deafness was due to another gene or that there was a mutation in a non-coding region of GJB2 not evaluated in the test. Recent identification of a 342 kb deletion in the GJB6 gene (D(GJB6-D13S1830)) as the second most frequent mutation causing prelingual deafness in the Spanish population may provide the sought after answer in many cases (68) . GJB6 maps within the same chromosomal region as GJB2, and these recently published data suggest that mutations in the DFNB1 locus can result in a monogenic or digenic pattern of inheritance. Of note, the typical mutationdetection assays commonly in use may miss such large deletions.
Genes for maintenance of hair cell function
Another group of genes of intense interest are those required for survival of sensory hair cells. The POU domain transcription factor gene POU4F3 is required for terminal differentiation and maintenance of inner hair cells and an 8 bp deletion in the POU homeodomain results in progressive hearing loss in DFNA15 (69) . Studies of such genes may result in valuable insight into the molecular triggers for hair cell degeneration. Loss of hair cells is presumed to be a fundamental cause of progressive age-related hearing loss (presbycusis) and an understanding of this degenerative process might provide the basis for therapeutic intervention. The recent finding of the transmembrane cochlear-expressed gene TMC1 uncovers a common cause of nonsyndromic recessive deafness in Pakistan and India at the DFNB7/B11 locus on chromosome 9 in bands q13-q21; mutations in TMC1 account for the deafness phenotype in 5.4 AE 3.0% of 230 families screened (12) . Cloning of TMC1 resulted from an interesting genomicsbased approach that first involved identification of a predicted gene (subsequently designated TMC2) on chromosome 20 with sequence similarity to query sequences in a tBLASTx analysis of a BAC from the linked genetic interval. TMC1 mutations were also found to be etiologic in DFNA36 (12) and in the mouse mutants deafness (dn) (12) and Beethoven (Bth) (50) . It is predicted that TMC1 protein may mediate an ion-transport or channel function required for the normal function of hair cells.
The recessive dn mutant displays no auditory response and has secondary hair cell degeneration and the dominant Bth mutant appears to have normally functioning hair cells prior to degeneration.
Modifier genes
Molecular analyses of the auditory system have already yielded a number of genes in mice and humans that influence the expression or function of other genes. Studies of these genes are certain to provide insight into the interaction of their gene products. Notable among the mouse genes are tub (tubby) and moth1 (modifier of tubby hearing) (70), and dfw (deafwaddler) and mdfw (modifier of deaf waddler) (71).
Moth1 can worsen or prevent the hearing impairment in tubby, depending upon the type of moth1 allele and whether one or both copies of the allele are functional. One allele of Mdfw can protect dfw heterozygotes from hearing loss, whereas another is permissive for hearing loss in dfw heterozygotes. In humans, the locus for a modifier gene (DFNM1) for the deafness haplotype in DFNB26 has been identified on chromosome 1 in band q24 (72) .
Mitochondrial genes
A variety of mitochondrial disorders have been found to involve hearing loss, perhaps reflecting the highly metabolic state of the hearing process (73) . Of particular interest has been the A1555!G mutation in 12S rRNA that is recognized as the most frequent cause of aminoglycoside-induced deafness and as the etiology of a nonsyndromic deafness (74) . In a recent study a nearly identical degree of mitochondrial dysfunction was observed in enucleated lymphoblastoid cells derived from both symptomatic and asymptomatic individuals from the same kindred (75) supporting the possibility of a nuclear gene in modifying the effect of the mutation. Investigations in hereditary deafness have revealed many lessons in genetics, foremost among them a sensory system with profound genotypic and phenotypic heterogeneity. Despite the recent tremendous successes in the genetics of deafness, our knowledge remains woefully incomplete. An astonishing number of deafness loci have been mapped in humans and mice, yet the genetic basis of many disorders remains unknown. Genomic approaches using a combination of methods of positional cloning, candidate genes and mouse models continue to yield new and novel genes providing valuable insight into the molecular basis of the process of hearing.
